BARD1 mutation

News alerts, weekly reports and conference planners

Entrez ID:

BARD1 mutation	Prostate Cancer	BARD1 mutation	Prostate Cancer	olaparib Sensitive: A2 - Guideline olaparib Sensitive : A2	olaparib Sensitive: A2 - Guideline olaparib Sensitive : A2
BARD1 mutation	Ovarian Cancer	BARD1 mutation	Ovarian Cancer	olaparib Sensitive: B - Late Trials olaparib Sensitive : B	olaparib Sensitive: B - Late Trials olaparib Sensitive : B
BARD1 mutation	HER2 Negative Breast Cancer	BARD1 mutation	HER2 Negative Breast Cancer	durvalumab Sensitive: C2 – Inclusion Criteria durvalumab Sensitive : C2	durvalumab Sensitive: C2 – Inclusion Criteria durvalumab Sensitive : C2

Associations